SIRT7 and lung carcinoma: Recently, we demonstrated that SIRT7 directly interacts with ARF in lung cancer cells and promotes its proteasomal-dependent degradation by inhibiting its interaction with NPM1.7 This event prevents ARF from repressing genes involved in stimulation of cancer cells growth, thereby facilitating lung cancer progression (Figure 1).7